Developer docs
API playgroundTry for free, no card

Search company profiles

Selfapy

Full company profile

uuid0000zio

Namestring
Selfapy
Legal namestring
Selfapy GmbH
Websiteurl
selfapy.com
Company typeenum
Private
Founded yearint
2016
Descriptiontext

Selfapy is a Berlin-based digital health company founded in 2013 that develops and operates CE-certified Class 1 medical device online therapy programs for mental health conditions. The company's core offering consists of six condition-specific 12-week programs based on cognitive behavioral therapy: Depression, Generalized Anxiety Disorder, Binge-Eating Disorder, Bulimia Nervosa, Chronic Pain, and Panic Disorder. Each program comprises 12 structured lessons featuring psychoeducational content, interactive exercises, videos, audio materials, and a digital mood diary, delivered via a web application (app.selfapy.com) and native iOS and Android apps. Programs are monitored by an in-house psychology team for safety, with keyword-based crisis detection and PHQ symptom tracking built into the workflow.

The company operates a prescription-driven B2B2C go-to-market model under Germany's DiGA (Digital Health Applications) regulatory framework. Four of the six programs (Depression, GAD, Binge-Eating, Bulimia) are listed in the BfArM DiGA directory and are 100% reimbursed by German statutory health insurers when prescribed by a physician or psychotherapist via PZN codes integrated into practice management software. Chronic Pain and Panic Disorder programs are available on a private-pay basis. Patients obtain activation codes through their health insurers, with Selfapy offering a free prescription submission service to streamline the process. Additional distribution occurs through a partnership with Teleclinic for telemedicine-mediated prescribing.

Selfapy has completed over 40,000 therapy courses and has validated its programs through randomized controlled trials conducted with Charité Berlin, Justus-Liebig-Universität Gießen, Universität Heidelberg, and Humboldt-Universität zu Berlin, reporting effect sizes such as Cohen's d of -0.85 for anxiety. The company has raised approximately €13.6M+ across six funding rounds from 2015 to 2023, with the most recent €7M round in February 2023 led by strategic pharmaceutical investor Medice Arzneimittel and designated for European market expansion and new digital therapeutic development. The company employs 51-100 people and is led by CEO Adham Kassab, with founders Nora Blum and Katrin Bermbach continuing in co-founder roles.

Short descriptiontext

Selfapy is a Berlin-based digital health company offering CE-certified, CBT-based online therapy programs for depression, anxiety, eating disorders, chronic pain, and panic disorder. Programs are prescribed by physicians and 100% reimbursed by German statutory health insurers under the DiGA framework.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersBerlin, Germany
HQ citystring
Berlin
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
online cognitive behavioral therapy, digital mental health programs, prescription digital therapeutics, guided self-help therapy, DiGA health applications
Industry3 codes
PRIMARYHLACANAI
Behavioral Health & Neurocognitive Therapeutics (Digital)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLALAEAA
General Mental Health Therapy Platforms (Talk Therapy)
Healthcare & Life Sciences/Telehealth Platforms/Behavioral & Mental Health Teletherapy Platforms
SECONDARYHLAFACAK
Eating Disorder Treatment Programs
Healthcare & Life Sciences/Healthcare Providers & Systems/Behavioral Health & Substance Use Treatment
NAICS code1 code
  • Outpatient Mental Health and Substance Abuse Centers62142
SIC code2 codes
  • Services-Health Services8000
  • Services-Specialty Outpatient Facilities, Nec8093
Product category
Digital Mental Health Therapeutics
Social media profiles1 record
Revenue model2 records
1DiGA Reimbursement (Digital Health Applications)
TypeSubscription Recurring
Description

Selfapy's core programs (Depression, Generalized Anxiety Disorder, Binge-Eating, Bulimia) are fully reimbursed by German statutory health insurers as certified DiGA (Digitale Gesundheitsanwendung). Patients pay nothing with a valid prescription. The company receives reimbursement through the German health insurance system.

selfapy.com
2Private Pay (Chronic Pain, Panic Disorder)
TypeOne Time License
Description

Programs for chronic pain and panic disorder are available for self-paying patients (not covered by statutory insurance), representing a private-pay revenue stream.

selfapy.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Pricing details1 tier
1DiGA Covered Programs (Depression, Anxiety, Eating Disorders) — 100% covered by statutory health insurance
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Fully covered for all German statutory health insurance patients with a valid prescription. No patient cost. Program duration: 12 weeks (90 days) with 12 lessons. Can be extended with a new prescription.

selfapy.com
GTM typeB2C
B2C
Offering typeSoftware
Software
Core offering1 text field

Selfapy provides CE-certified Class 1 medical device online therapy programs based on cognitive behavioral therapy (CBT) for mental health conditions including depression, generalized anxiety disorder, binge-eating disorder, bulimia nervosa, chronic pain, and panic disorder. Each program is a structured 12-week course of 12 lessons delivered via web application and native mobile apps (iOS/Android), with psychologist oversight for safety monitoring. The core programs for depression, anxiety, and eating disorders are fully reimbursed by German statutory health insurers under the DiGA framework.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 39.5% average reduction in depressive symptoms after 12-week Selfapy program without psychological support (401 participants, randomized controlled study)
+4 more records
Product overview1 text field

Selfapy is a Berlin-based digital health company offering a platform of CE-certified Class 1 medical device online therapy programs for mental health conditions. The core offering consists of six condition-specific therapy programs: Depression, Generalized Anxiety Disorder, Binge-Eating Disorder, Bulimia Nervosa, Chronic Pain, and Panic Disorder. Each program is a 12-week guided self-help course based on cognitive behavioral therapy, comprising 12 structured lessons with psychoeducational content, interactive exercises, videos, audio materials, and a digital mood diary. Programs are accessible via web application and mobile apps (iOS/Android) and are prescribed by healthcare providers using PZN codes. For depression, anxiety, and eating disorders, costs are covered 100% by German statutory health insurers under the DiGA (Digital Health Applications) framework. Psychologist oversight is provided throughout each course for safety monitoring and user support. Additional services include a free prescription submission service, course renewal options, and crisis support features.

Product and service8 records
1Online Therapy Program - Depression
CategoryDigital Therapeutics
Description

A 12-week CE-certified online therapy program for adults with depression, based on cognitive behavioral therapy, comprising 12 lessons on psychoeducation and practical exercises. Costs are covered 100% by German statutory health insurers with a valid prescription.

2Online Therapy Program - Generalized Anxiety Disorder
CategoryDigital Therapeutics
Description

A 12-week CE-certified online therapy program for adults with generalized anxiety disorder, using cognitive behavioral therapy methods including psychoeducational content and practical exercises. Prescribable via PZN 17554323; costs covered 100% by German statutory health insurers.

3Online Therapy Program - Binge-Eating Disorder
CategoryDigital Therapeutics
Description

A 12-week CE-certified online therapy program for adults with binge-eating disorder, based on CBT with 12 lessons on emotion and stress regulation, self-esteem, mindfulness, social competence, and pleasure training. First certified DiGA for eating disorders in Germany.

4Online Therapy Program - Bulimia Nervosa
CategoryDigital Therapeutics
Description

A 12-week CE-certified online therapy program for adults with bulimia nervosa, using CBT methods including 12 lessons on psychoeducation, emotion regulation, self-esteem, and mindfulness. First certified DiGA for eating disorders in Germany.

5Online Therapy Program - Chronic Pain
CategoryDigital Therapeutics
Description

A 12-week online therapy program for adults with chronic pain conditions, based on evidence-based methods from behavioral therapy and mindfulness and commitment therapy. Available as a private-pay option via PZN 18759010.

6Online Therapy Program - Panic Disorder
CategoryDigital Therapeutics
Description

An online therapy program for adults with panic disorder, based on cognitive behavioral therapy principles. Currently available for self-paying patients (private pay).

7Selfapy Mobile App (iOS/Android)
CategoryDigital Platform
Description

Native mobile applications for iOS and Android that provide access to all Selfapy therapy programs, including lesson content, interactive exercises, and a digital mood diary with calendar integration.

8Selfapy Web Application
CategoryDigital Platform
Description

Browser-based web application at app.selfapy.com available on desktop and mobile browsers. Users register and enter a 16-digit activation code to access therapy programs.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Teleclinic provides online medical consultations (telemedicine) enabling patients to receive prescriptions for Selfapy's Depression and Generalized Anxiety Disorder programs within 2 hours, without visiting a physical doctor's office.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Charité Berlin conducted clinical validation of Selfapy's Depression program. The effectiveness of the depression course was clinically confirmed by Charité Berlin researchers.

3Justus-Liebig-Universität Gießen
Strategic tierMajorTypeStrategic or Co-development Partner
Description

Justus-Liebig-Universität Gießen conducted a randomized controlled evaluation study of Selfapy's Generalized Anxiety Disorder program with 156 participants, demonstrating significant symptom reduction (Cohen's d = -0.85) and 41.3% improvement in health-related quality of life.

selfapy.com
Strategic tierMajorTypeStrategic or Co-development Partner
Description

Universität Heidelberg conducted two randomized controlled studies evaluating Selfapy's Binge-Eating Disorder and Bulimia programs. The studies demonstrated significant symptom reduction with Cohen's d = -0.79 for Binge-Eating and Cohen's d = -0.50 for Bulimia.

5Humboldt-Universität zu Berlin
Strategic tierMajorTypeStrategic or Co-development Partner
Description

Humboldt-Universität zu Berlin is conducting an ongoing evaluation study of Selfapy's Chronic Pain program in collaboration with the Institute of Psychology. Pilot data showed significant reduction in pain symptoms.

selfapy.com
Strategic tierMinorTypeGTM or Marketing Partner
Description

Selfapy co-organizes regular CME webinars on DiGA in mental health with the Spitzenverband Digitale Gesundheitsversorgung (umbrella association for digital health provision). Participants earn 3 CME points.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

HelloBetter (formerly GET.ON) is a direct German DiGA competitor offering CBT-based online therapy programs for depression, anxiety, insomnia, and stress, reimbursed under the same DiGA framework. It targets the identical prescribing physician and statutory health insurance workflow that Selfapy relies on, and is one of the most well-funded competitors in the German digital mental health space.

TypeDirect peer
Description

Mindance is a German DiGA-certified mental health platform offering online courses for stress, burnout, and anxiety under the same statutory reimbursement pathway. It directly competes for prescribers, insurer attention, and patient mindshare in the German market.

TypeDirect peer
Description

Sympatient offers DiGA-listed VR-based exposure therapy for anxiety disorders including phobias, OCD, and panic disorder. It competes directly with Selfapy's panic disorder program and broader anxiety indications under the same German reimbursement framework.

TypeBroad incumbent
Description

BetterHelp is the largest global online therapy platform, offering unlimited messaging and live sessions with licensed therapists via subscription. While it operates on a human-delivered rather than self-guided model and lacks DiGA certification, it represents the incumbent online therapy consumer brand against which Selfapy's value proposition is benchmarked.

TypeBroad incumbent
Description

Headspace Health (the combination of Headspace and Ginger) is a broad mental health platform offering meditation, self-guided content, and on-demand therapist/coaching services. It serves as a benchmark for consumer mental health brands and employer distribution at scale, contrasting Selfapy's clinically validated, prescription-driven model.

TypeBroad incumbent
Description

Talkspace is a publicly traded online therapy platform connecting users to licensed therapists via messaging, audio, and video. It operates a similar therapist-monitored digital care model and competes for employer and insurer contracts in the same broader category as Selfapy.

TypeEmerging player
Description

Meru Health is a digital mental health program combining clinician-led care with app-based CBT content for depression, anxiety, and burnout. It targets employers and health plans with a hybrid human-plus-digital model that intersects with Selfapy's therapist-monitored self-help approach.

TypeEmerging player
Description

Wysa is an AI-augmented mental health chatbot offering CBT-based self-help, with employer and health plan distribution. It represents an emerging digitally delivered mental health solution that overlaps with Selfapy's self-guided CBT programs while pursuing different evidence and reimbursement strategies.

TypeEmerging player
Description

Big Health develops evidence-based digital therapeutics (e.g., Sleepio for insomnia, Daylight for anxiety) with FDA clearance and employer/health plan distribution. It is comparable to Selfapy as a prescription-class digital therapeutic in mental health, though focused on different geographies and indications.

TypeRegional player
Description

Oviva is a European digital health company offering app-based therapeutic programs for obesity, diabetes, and related conditions, with strong presence in Germany, Switzerland, and the UK under similar reimbursement models. While focused on physical rather than mental health, it is comparable as a DiGA-equivalent digital therapeutic operating across European statutory reimbursement systems.

Market position
Strengths1 record

Each record includes

Headline, Details, Source

Weaknesses1 record

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds6 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors11 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Selfapy

Digital Mental Health Therapeuticsselfapy.com

Selfapy is a Berlin-based digital health company offering CE-certified, CBT-based online therapy programs for depression, anxiety, eating disorders, chronic pain, and panic disorder. Programs are prescribed by physicians and 100% reimbursed by German statutory health insurers under the DiGA framework.

What Selfapy does

Selfapy is a Berlin-based digital health company founded in 2013 that develops and operates CE-certified Class 1 medical device online therapy programs for mental health conditions. The company's core offering consists of six condition-specific 12-week programs based on cognitive behavioral therapy: Depression, Generalized Anxiety Disorder, Binge-Eating Disorder, Bulimia Nervosa, Chronic Pain, and Panic Disorder. Each program comprises 12 structured lessons featuring psychoeducational content, interactive exercises, videos, audio materials, and a digital mood diary, delivered via a web application (app.selfapy.com) and native iOS and Android apps. Programs are monitored by an in-house psychology team for safety, with keyword-based crisis detection and PHQ symptom tracking built into the workflow.

The company operates a prescription-driven B2B2C go-to-market model under Germany's DiGA (Digital Health Applications) regulatory framework. Four of the six programs (Depression, GAD, Binge-Eating, Bulimia) are listed in the BfArM DiGA directory and are 100% reimbursed by German statutory health insurers when prescribed by a physician or psychotherapist via PZN codes integrated into practice management software. Chronic Pain and Panic Disorder programs are available on a private-pay basis. Patients obtain activation codes through their health insurers, with Selfapy offering a free prescription submission service to streamline the process. Additional distribution occurs through a partnership with Teleclinic for telemedicine-mediated prescribing.

Selfapy has completed over 40,000 therapy courses and has validated its programs through randomized controlled trials conducted with Charité Berlin, Justus-Liebig-Universität Gießen, Universität Heidelberg, and Humboldt-Universität zu Berlin, reporting effect sizes such as Cohen's d of -0.85 for anxiety. The company has raised approximately €13.6M+ across six funding rounds from 2015 to 2023, with the most recent €7M round in February 2023 led by strategic pharmaceutical investor Medice Arzneimittel and designated for European market expansion and new digital therapeutic development. The company employs 51-100 people and is led by CEO Adham Kassab, with founders Nora Blum and Katrin Bermbach continuing in co-founder roles.

Selfapy firmographics

Firmographics
Name
Selfapy
Legal name
Selfapy GmbH
Website
https://selfapy.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
11–50 employees
Short description
Selfapy is a Berlin-based digital health company offering CE-certified, CBT-based online therapy programs for depression, anxiety, eating disorders, chronic pain, and panic disorder. Programs are prescribed by physicians and 100% reimbursed by German statutory health insurers under the DiGA framework.
Ownership category
akta.pro rank

Selfapy industry classification

Industry
Product category
Digital Mental Health Therapeutics
NAICS
Outpatient Mental Health and Substance Abuse Centers (62142)
SIC
Services-Health Services (8000), Services-Specialty Outpatient Facilities, Nec (8093)
akta.pro industry
PRIMARYHLACANAI
Behavioral Health & Neurocognitive Therapeutics (Digital)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLALAEAA
General Mental Health Therapy Platforms (Talk Therapy)
Healthcare & Life Sciences/Telehealth Platforms/Behavioral & Mental Health Teletherapy Platforms
SECONDARYHLAFACAK
Eating Disorder Treatment Programs
Healthcare & Life Sciences/Healthcare Providers & Systems/Behavioral Health & Substance Use Treatment

Keywords

  • Online cognitive behavioral therapy
  • Digital mental health programs
  • Prescription digital therapeutics
  • Guided self-help therapy
  • DiGA health applications

Where Selfapy is headquartered

Location

Headquarters

HQ city
Berlin
HQ country
Germany
HQ region
Europe

Offices1 record

Markets served

Selfapy business model

Business model
GTM type
B2C
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. DiGA Reimbursement (Digital Health Applications): Selfapy's core programs (Depression, Generalized Anxiety Disorder, Binge-Eating, Bulimia) are fully reimbursed by German statutory health insurers as certified DiGA (Digitale Gesundheitsanwendung). Patients pay nothing with a valid prescription. The company receives reimbursement through the German health insurance system.
  2. Private Pay (Chronic Pain, Panic Disorder): Programs for chronic pain and panic disorder are available for self-paying patients (not covered by statutory insurance), representing a private-pay revenue stream.

Pricing tiers

ModelBillingPrice
SubscriptionMulti-year contractDiGA Covered Programs (Depression, Anxiety, Eating Disorders) — 100% covered by statutory health insurance

Distribution channels4 records

Marketing channels7 records

Selfapy product offering

Product offering

Core offering

Selfapy provides CE-certified Class 1 medical device online therapy programs based on cognitive behavioral therapy (CBT) for mental health conditions including depression, generalized anxiety disorder, binge-eating disorder, bulimia nervosa, chronic pain, and panic disorder. Each program is a structured 12-week course of 12 lessons delivered via web application and native mobile apps (iOS/Android), with psychologist oversight for safety monitoring. The core programs for depression, anxiety, and eating disorders are fully reimbursed by German statutory health insurers under the DiGA framework.

Product overview

Selfapy is a Berlin-based digital health company offering a platform of CE-certified Class 1 medical device online therapy programs for mental health conditions. The core offering consists of six condition-specific therapy programs: Depression, Generalized Anxiety Disorder, Binge-Eating Disorder, Bulimia Nervosa, Chronic Pain, and Panic Disorder. Each program is a 12-week guided self-help course based on cognitive behavioral therapy, comprising 12 structured lessons with psychoeducational content, interactive exercises, videos, audio materials, and a digital mood diary. Programs are accessible via web application and mobile apps (iOS/Android) and are prescribed by healthcare providers using PZN codes. For depression, anxiety, and eating disorders, costs are covered 100% by German statutory health insurers under the DiGA (Digital Health Applications) framework. Psychologist oversight is provided throughout each course for safety monitoring and user support. Additional services include a free prescription submission service, course renewal options, and crisis support features.

Differentiator

Problem solved

Functional benefit

Products and services

  • Online Therapy Program - Depression A 12-week CE-certified online therapy program for adults with depression, based on cognitive behavioral therapy, comprising 12 lessons on psychoeducation and practical exercises. Costs are covered 100% by German statutory health insurers with a valid prescription.
  • Online Therapy Program - Generalized Anxiety Disorder A 12-week CE-certified online therapy program for adults with generalized anxiety disorder, using cognitive behavioral therapy methods including psychoeducational content and practical exercises. Prescribable via PZN 17554323; costs covered 100% by German statutory health insurers.
  • Online Therapy Program - Binge-Eating Disorder A 12-week CE-certified online therapy program for adults with binge-eating disorder, based on CBT with 12 lessons on emotion and stress regulation, self-esteem, mindfulness, social competence, and pleasure training. First certified DiGA for eating disorders in Germany.
  • Online Therapy Program - Bulimia Nervosa A 12-week CE-certified online therapy program for adults with bulimia nervosa, using CBT methods including 12 lessons on psychoeducation, emotion regulation, self-esteem, and mindfulness. First certified DiGA for eating disorders in Germany.
  • Online Therapy Program - Chronic Pain A 12-week online therapy program for adults with chronic pain conditions, based on evidence-based methods from behavioral therapy and mindfulness and commitment therapy. Available as a private-pay option via PZN 18759010.
  • Online Therapy Program - Panic Disorder An online therapy program for adults with panic disorder, based on cognitive behavioral therapy principles. Currently available for self-paying patients (private pay).
  • Selfapy Mobile App (iOS/Android) Native mobile applications for iOS and Android that provide access to all Selfapy therapy programs, including lesson content, interactive exercises, and a digital mood diary with calendar integration.
  • Selfapy Web Application Browser-based web application at app.selfapy.com available on desktop and mobile browsers. Users register and enter a 16-digit activation code to access therapy programs.

Quantifiable outcome

  • 39.5% average reduction in depressive symptoms after 12-week Selfapy program without psychological support (401 participants, randomized controlled study)
  • +4 more outcomes

Companies that use Selfapy

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Selfapy technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

Feature4 records

Selfapy partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core, major and minor.

  • TelecliniccoreChannel Partner/ Reseller/ DistributorTeleclinic provides online medical consultations (telemedicine) enabling patients to receive prescriptions for Selfapy's Depression and Generalized Anxiety Disorder programs within 2 hours, without visiting a physical doctor's office.
  • Charité BerlinmajorStrategic or Co-development PartnerCharité Berlin conducted clinical validation of Selfapy's Depression program. The effectiveness of the depression course was clinically confirmed by Charité Berlin researchers.
  • Justus-Liebig-Universität GießenmajorStrategic or Co-development PartnerJustus-Liebig-Universität Gießen conducted a randomized controlled evaluation study of Selfapy's Generalized Anxiety Disorder program with 156 participants, demonstrating significant symptom reduction (Cohen's d = -0.85) and 41.3% improvement in health-related quality of life.
  • Universität HeidelbergmajorStrategic or Co-development PartnerUniversität Heidelberg conducted two randomized controlled studies evaluating Selfapy's Binge-Eating Disorder and Bulimia programs. The studies demonstrated significant symptom reduction with Cohen's d = -0.79 for Binge-Eating and Cohen's d = -0.50 for Bulimia.
  • Humboldt-Universität zu BerlinmajorStrategic or Co-development PartnerHumboldt-Universität zu Berlin is conducting an ongoing evaluation study of Selfapy's Chronic Pain program in collaboration with the Institute of Psychology. Pilot data showed significant reduction in pain symptoms.
  • Spitzenverband Digitale GesundheitsversorgungminorGTM or Marketing PartnerSelfapy co-organizes regular CME webinars on DiGA in mental health with the Spitzenverband Digitale Gesundheitsversorgung (umbrella association for digital health provision). Participants earn 3 CME points.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Selfapy competitors and assessment

Company assessment

Direct peers

  • HelloBetter: HelloBetter (formerly GET.ON) is a direct German DiGA competitor offering CBT-based online therapy programs for depression, anxiety, insomnia, and stress, reimbursed under the same DiGA framework. It targets the identical prescribing physician and statutory health insurance workflow that Selfapy relies on, and is one of the most well-funded competitors in the German digital mental health space.
  • Mindance: Mindance is a German DiGA-certified mental health platform offering online courses for stress, burnout, and anxiety under the same statutory reimbursement pathway. It directly competes for prescribers, insurer attention, and patient mindshare in the German market.
  • Sympatient: Sympatient offers DiGA-listed VR-based exposure therapy for anxiety disorders including phobias, OCD, and panic disorder. It competes directly with Selfapy's panic disorder program and broader anxiety indications under the same German reimbursement framework.

Broad incumbents

  • BetterHelp: BetterHelp is the largest global online therapy platform, offering unlimited messaging and live sessions with licensed therapists via subscription. While it operates on a human-delivered rather than self-guided model and lacks DiGA certification, it represents the incumbent online therapy consumer brand against which Selfapy's value proposition is benchmarked.
  • Headspace Health: Headspace Health (the combination of Headspace and Ginger) is a broad mental health platform offering meditation, self-guided content, and on-demand therapist/coaching services. It serves as a benchmark for consumer mental health brands and employer distribution at scale, contrasting Selfapy's clinically validated, prescription-driven model.
  • Talkspace: Talkspace is a publicly traded online therapy platform connecting users to licensed therapists via messaging, audio, and video. It operates a similar therapist-monitored digital care model and competes for employer and insurer contracts in the same broader category as Selfapy.

Emerging players

  • Meru Health: Meru Health is a digital mental health program combining clinician-led care with app-based CBT content for depression, anxiety, and burnout. It targets employers and health plans with a hybrid human-plus-digital model that intersects with Selfapy's therapist-monitored self-help approach.
  • Wysa: Wysa is an AI-augmented mental health chatbot offering CBT-based self-help, with employer and health plan distribution. It represents an emerging digitally delivered mental health solution that overlaps with Selfapy's self-guided CBT programs while pursuing different evidence and reimbursement strategies.
  • Big Health: Big Health develops evidence-based digital therapeutics (e.g., Sleepio for insomnia, Daylight for anxiety) with FDA clearance and employer/health plan distribution. It is comparable to Selfapy as a prescription-class digital therapeutic in mental health, though focused on different geographies and indications.

Regional players

  • Oviva: Oviva is a European digital health company offering app-based therapeutic programs for obesity, diabetes, and related conditions, with strong presence in Germany, Switzerland, and the UK under similar reimbursement models. While focused on physical rather than mental health, it is comparable as a DiGA-equivalent digital therapeutic operating across European statutory reimbursement systems.

Market position

Strengths1 record

Weaknesses1 record

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Selfapy social profiles

Digital presence

Selfapy compliance and trust

Trust signal

Compliance3 records

Selfapy financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Selfapy leadership team

Management profile

Number of profiles

Profiles3 records

Selfapy funding detail

Funding detail

Funding overview

Funding rounds6 records

Investors11 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Selfapy M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Selfapy

What does Selfapy do?

Selfapy provides CE-certified Class 1 medical device online therapy programs based on cognitive behavioral therapy (CBT) for mental health conditions including depression, generalized anxiety disorder, binge-eating disorder, bulimia nervosa, chronic pain, and panic disorder. Each program is a structured 12-week course of 12 lessons delivered via web application and native mobile apps (iOS/Android), with psychologist oversight for safety monitoring. The core programs for depression, anxiety, and eating disorders are fully reimbursed by German statutory health insurers under the DiGA framework.

Is Selfapy a public or private company?

Selfapy is a private company. It is classified as venture growth investor backed and is currently operating.

When was Selfapy founded?

Selfapy was founded in 2016. It employs 11 to 50 people.

Where is Selfapy based?

Selfapy is headquartered in Berlin, Germany, in the Europe region.

How does Selfapy make money?

Two revenue lines are on record. DiGA Reimbursement (Digital Health Applications) is the primary driver. The others are private Pay (Chronic Pain, Panic Disorder).

Who are Selfapy's main competitors?

Direct peers on record are HelloBetter, Mindance and Sympatient. Broad incumbents are BetterHelp, Headspace Health and Talkspace. Emerging players are Meru Health, Wysa and Big Health. Oviva is listed as a regional player.

Does Selfapy have an API?

No public API is recorded for Selfapy.

What industry is Selfapy in?

Selfapy's product category is Digital Mental Health Therapeutics. Its primary akta.pro industry code is HLACANAI, Behavioral Health & Neurocognitive Therapeutics (Digital), with a secondary code of HLALAEAA, General Mental Health Therapy Platforms (Talk Therapy). Its NAICS code is 62142 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
FinSMEsSelfapy Raises €7M in FundingBerlin-based digital health company Selfapy has closed a €7 million financing round led by Medice Arzneimittel, with participation from investors SHS, Think.Health Ventures, IBB Ventures, and HTGF. The company plans to utilize these funds to expand its digital therapeutics portfolio for mental health disorders and enter new European markets.BufferSelfapy's digital self-service mental health platform nets €7 millionBerlin-based Selfapy has secured a €7 million investment round led by Medice Arzneimittel to support domestic growth and European expansion of its digital mental health platform. The funding, which includes participation from SHS, Think.Health Ventures, and IBB Ventures, will help scale treatments for conditions such as depression, anxiety, and eating disorders that are reimbursed by German statutory health insurance.IBB VenturesSelfapy brings a strategic investor on boardDigital health company Selfapy secured a 7 million euro financing round led by strategic investor Medice Arzneimittel, with participation from existing investors including SHS and IBB Ventures. The capital will be utilized to expand its portfolio of reimbursed digital therapeutics for mental health disorders in Germany and enter new European markets.HealthcaremarketingSelfapy erweitert GeschäftsführungAdham Kassab, who has served as COO and CFO since February 2022, will become co-CEO of Selfapy alongside founder Nora Blum and Katrin Bermbach. He will oversee strategic management, investor relations, and expansion into new mental-health areas. Kassab plans to launch three additional courses and pursue internationalization.Deutsche WelleThe pandemic harms the mind, helps an industryThe pandemic has boosted demand for digital mental health services, with Germany's Selfapy seeing nearly three times more contacts. The company received a €6 million grant and now covers course costs via health insurance. Founders and investors expect the market to grow post-crisis as mental health awareness remains high.FinSMEsSelfapy Raises €6M in FundingSelfapy, a Berlin-based digital therapy provider, raised €6M in funding from SHS and previous investors. The company will use the funds for national and international expansion, product development, and clinical validation. It has treated over 15,000 patients and cooperates with 16 health insurers.PitchBookNew Year’s resolutions: Meet the startups taking care of your well-beingThree startups—Selfapy, Headspace, and Onera—offer mental health and sleep services. Selfapy provides online therapy, Headspace offers meditation, and Onera sells a sleep patch. The article notes mental health costs EU countries over €600 billion annually.FinSMEsSelfapy Raises Seven-Figure FundingSelfapy, a Berlin-based digital health startup, raised a seven-figure funding round from High-Tech Gründerfonds, IBB Beteiligungsgesellschaft, and business angels. The undisclosed amount will be used to expand in B2C and B2B sectors. The company offers online therapy courses for mental disorders, having served over 2,000 people since 2016.